Company intelligence / Profile preview

LevitasBio

Menlo Park, California, United Stateslevitasbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

LevitasBio has commercialized the LeviCell® platform, which enables gentle, label-free isolation and enrichment of viable cells from complex samples. The technology preserves biological integrity for downstream applications such as single-cell genomics and flow cytometry. No clinical results as the company provides research tools rather than therapeutics.

Therapeutic areas: Other
Modalities: Device
Industry: Non-Drug Biotech

Partnerships

None specifically listed in public sources; focus appears to be direct sales to academic and industry researchers.

Beyond the preview

Go deeper on LevitasBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LevitasBio.

Explore the full profile